METH-2 silencing and promoter hypermethylation in NSCLC

por Dunn, J R, Panutsopulos, D, Shaw, M W, Heighway, J, Dormer, R, Salmo, E N, Watson, S G, Field, J K, Liloglou, T
Publicado 2004

Lessons from the ‘Iressa’ Expanded Access Programme: gefitinib in special non-small-cell lung cancer patient populations

por Stahel, R, Rossi, A, Petruzelka, L, Kosimidis, P, de Braud, F, Bernardo, M M, Souquet, P-J, Parra, H Soto, Gridelli, C
Publicado 2003

Extensive experience of disease control with gefitinib and the role of prognostic markers

por Cortes-Funes, H, Soto Parra, H
Publicado 2003

Treatment of non-small-cell lung cancer: a perspective on the recent advances and the experience with gefitinib

por Onn, A, Tsuboi, M, Thatcher, N
Publicado 2004

Cancer phenotype as the outcome of an evolutionary game between normal and malignant cells

por Dingli, D, Chalub, F A C C, Santos, F C, Van Segbroeck, S, Pacheco, J M
Publicado 2009

Cause-specific mortality in classic Kaposi's sarcoma: a population-based study in Italy (1995–2002)

por Ascoli, V, Minelli, G, Kanieff, M, Crialesi, R, Frova, L, Conti, S
Publicado 2009

Pancreatic cancer cells resistance to gemcitabine: the role of MUC4 mucin

por Bafna, S, Kaur, S, Momi, N, Batra, S K
Publicado 2009

Effects of VEGFR-3 phosphorylation inhibitor on lymph node metastasis in an orthotopic diffuse-type gastric carcinoma model

por Yashiro, M, Shinto, O, Nakamura, K, Tendo, M, Matsuoka, T, Matsuzaki, T, Kaizaki, R, Ohira, M, Miwa, A, Hirakawa, K
Publicado 2009

Capecitabine in combination with irinotecan (XELIRI), administered as a 2-weekly schedule, as first-line chemotherapy for patients with metastatic colorectal cancer: a phase II stu...

por Garcia-Alfonso, P, Muñoz-Martin, A, Mendez-Ureña, M, Quiben-Pereira, R, Gonzalez-Flores, E, Perez-Manga, G
Publicado 2009

Cannabis, tobacco and domestic fumes intake are associated with nasopharyngeal carcinoma in North Africa

por Feng, B-J, Khyatti, M, Ben-Ayoub, W, Dahmoul, S, Ayad, M, Maachi, F, Bedadra, W, Abdoun, M, Mesli, S, Bakkali, H, Jalbout, M, Hamdi-Cherif, M, Boualga, K, Bouaouina, N, Chouchane, L, Benider, A, Ben-Ayed, F, Goldgar, D E, Corbex, M
Publicado 2009

Chronic lymphocytic leukaemia patients have a high risk of Merkel-cell polyomavirus DNA-positive Merkel-cell carcinoma

por Koljonen, V, Kukko, H, Pukkala, E, Sankila, R, Böhling, T, Tukiainen, E, Sihto, H, Joensuu, H
Publicado 2009

Inflammation and tissue repair markers distinguish the nodular sclerosis and mixed cellularity subtypes of classical Hodgkin's lymphoma

por Birgersdotter, A, Baumforth, K R N, Porwit, A, Sjöberg, J, Wei, W, Björkholm, M, Murray, P G, Ernberg, I
Publicado 2009

GATA factors in human neuroblastoma: distinctive expression patterns in clinical subtypes

por Hoene, V, Fischer, M, Ivanova, A, Wallach, T, Berthold, F, Dame, C
Publicado 2009

Glucocorticoid therapy and risk of bladder cancer

por Dietrich, K, Schned, A, Fortuny, J, Heaney, J, Marsit, C, Kelsey, K T, Karagas, M R
Publicado 2009

Synergistic anti-cancer effects of immunotoxin and cyclosporin in vitro and in vivo

por Andersson, Y, Engebraaten, O, Fodstad, Ø
Publicado 2009

DKC1 overexpression associated with prostate cancer progression

por Sieron, P, Hader, C, Hatina, J, Engers, R, Wlazlinski, A, Müller, M, Schulz, W A
Publicado 2009

Human leukocyte antigen class I expression is an independent prognostic factor in advanced ovarian cancer resistant to first-line platinum chemotherapy

por Shehata, M, Mukherjee, A, Deen, S, Al-Attar, A, Durrant, L G, Chan, S
Publicado 2009

Tetraspanin-induced death of myeloma cell lines is autophagic and involves increased UPR signalling

por Zismanov, V, Lishner, M, Tartakover-Matalon, S, Radnay, J, Shapiro, H, Drucker, L
Publicado 2009

Molecular characteristics of screen-detected vs symptomatic breast cancers and their impact on survival

por Dawson, S J, Duffy, S W, Blows, F M, Driver, K E, Provenzano, E, LeQuesne, J, Greenberg, D C, Pharoah, P, Caldas, C, Wishart, G C
Publicado 2009

Open-label, clinical phase I studies of tasquinimod in patients with castration-resistant prostate cancer

por Bratt, O, Häggman, M, Ahlgren, G, Nordle, Ö, Björk, A, Damber, J-E
Publicado 2009